(BLRX) |
| 0 (0%) 10-10 16:16 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 4.56 |
| Resistance 1: | 4.17 |
| Pivot price: | 3.97 |
| Support 1: | 3.54 |
| Support 2: | 2.95 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -6.000 |
| Book Value | 0.010 |
| PEG Ratio | 0.00 |
| Gross Profit | 2.401 |
| Profit Margin (%) | -45.34 |
| Operating Margin (%) | -757.57 |
| Return on Assets (ttm) | -15.4 |
| Return on Equity (ttm) | -45.9 |
Company news
Fri, 10 Oct 2025
Tools to assess BLRX’s risk profile - July 2025 EndofMonth & Fast Momentum Entry Tips - newser.com
Fri, 10 Oct 2025
Reversal indicators forming on BLRX stock - Weekly Investment Summary & AI Optimized Trading Strategy Guides - newser.com
Tue, 30 Sep 2025
BLRX: A Venture into GBM - Yahoo Finance
Thu, 14 Aug 2025
BioLineRx Plans New Drug Pipeline Deal as Cash Runway Stretches to 2027 - Stock Titan
Thu, 14 Aug 2025
BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update - PR Newswire
Thu, 07 Aug 2025
BioLineRx Q2 2025 Earnings: Oncology Biotech Developer Updates Investors Next Week - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
